Stay updated on Duvelisib for COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Duvelisib for COVID-19 Clinical Trial page.

Latest updates to the Duvelisib for COVID-19 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.0 was removed and v3.4.1 added, a minor software update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page's revision label updated from v3.3.3 to v3.3.4, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA standalone Locations section now lists Missouri as a site, replacing the former Missouri Locations block; the HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedUpdated the Publications section to clarify that publications are automatically filled from PubMed and may not all pertain to the study. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Duvelisib for COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib for COVID-19 Clinical Trial page.